We are live on ! Find out more
ELEV

Elevation Oncology

Delisted

ELEV was delisted on the 22nd of July, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
TCM
1
Tang Capital Management
California
$1.97M -$176K -332,400 -8%
Millennium Management
2
Millennium Management
New York
$1.61M -$22.2K -41,935 -1%
VP
3
venBio Partners
California
$1.56M
ACM
4
Aisling Capital Management
New York
$1.52M
QUSVM
5
Qiming U.S. Ventures Management
Washington
$1.27M
BI
6
BVF Inc
California
$1.24M
O
7
OrbiMed
New York
$806K
IC
8
Ikarian Capital
Texas
$629K
Vanguard Group
9
Vanguard Group
Pennsylvania
$629K +$53.7K +101,441 +9%
SFM
10
Sphera Funds Management
Israel
$483K
Citadel Advisors
11
Citadel Advisors
Florida
$318K -$132K -248,718 -30%
Hudson Bay Capital Management
12
Hudson Bay Capital Management
Connecticut
$293K
VCIM
13
Velan Capital Investment Management
Georgia
$267K
DCM
14
DAFNA Capital Management
California
$242K
Renaissance Technologies
15
Renaissance Technologies
New York
$237K +$234K +441,490 New
Two Sigma Investments
16
Two Sigma Investments
New York
$196K -$39K -73,696 -17%
BFM
17
Boothbay Fund Management
New York
$138K
Geode Capital Management
18
Geode Capital Management
Massachusetts
$124K
Bank of America
19
Bank of America
North Carolina
$83K +$11 +21 +0%
UBS Group
20
UBS Group
Switzerland
$69K +$2.07K +3,904 +3%
Two Sigma Advisers
21
Two Sigma Advisers
New York
$55.1K +$13.7K +25,900 +34%
BlackRock
22
BlackRock
New York
$43.3K +$22.9K +43,249 +116%
AC
23
Annandale Capital
Texas
$27K
Northern Trust
24
Northern Trust
Illinois
$23.9K
State Street
25
State Street
Massachusetts
$22.6K